Publication

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Explore advances in model-informed precision dosing (MIPD) for pediatric antimicrobial therapy, including population PK modeling,…

CertaraJuly 29, 2026

Poster

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

See how Simcyp Simulator V20–V24 DDI predictions were shown equivalent to the EMA-qualified V19 using…

CertaraJuly 24, 2026

Blog

Important drug development questions that model-based meta-analysis answers

Explore drug development questions that model-based meta-analysis answers, from competitive positioning to dose selection &…

Danielle PillsburyJuly 23, 2026

Poster

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…

CertaraJuly 20, 2026

Conference

EANM 2026

–

Danielle PillsburyJuly 20, 2026

Webinar

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Hunter Stephens, PhDJuly 17, 2026

Blog

Model smarter, not harder: How Phoenix Cloud puts the science back at the center of modeling

Certara Model Designer brings cloud based pharmacometric modeling to your browser, with a curated model…

Arjen BosJuly 16, 2026

Publication

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

Explore how model-based meta-analysis supports dose optimization, trial design, and regulatory decisions, plus emerging roles…

CertaraJuly 16, 2026

Blog

When to conduct hepatic impairment studies and when modeling may be enough

How to decide if a hepatic impairment study is required, choose the right study design,…

CertaraJuly 13, 2026

Conference

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

CertaraJuly 9, 2026

Model Informed Drug Development

Advances and Challenges in Model-Informed Precision Dosing of Antimicrobials for Pediatric Patients

Assessing Cross-Version Simcyp Simulator Prediction Performance Using a Bioequivalence Framework to Support EMA Qualification

Important drug development questions that model-based meta-analysis answers

A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans

EANM 2026

CHI Webinar: From Dosimetry to Dose Decisions How Clinical Pharmacology and Model-Informed Approaches Are Shaping TRT Development

Model smarter, not harder: How Phoenix Cloud puts the science back at the center of modeling

Current State-of-the-Art and Future Advancements of Model-Based Meta-Analysis

When to conduct hepatic impairment studies and when modeling may be enough

ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop

Newsletter sign up

Quick links

Solutions

Contact